Your browser doesn't support javascript.
loading
A next-generation sequencing-based assay for minimal residual disease assessment in AML patients with FLT3-ITD mutations.
Levis, Mark J; Perl, Alexander E; Altman, Jessica K; Gocke, Christopher D; Bahceci, Erkut; Hill, Jason; Liu, Chaofeng; Xie, Zhiyi; Carson, Andrew R; McClain, Valerie; Stenzel, Timothy T; Miller, Jeffrey E.
Afiliação
  • Levis MJ; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD.
  • Perl AE; University of Pennsylvania-Abramson Comprehensive Cancer Center, Philadelphia, PA.
  • Altman JK; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL.
  • Gocke CD; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD.
  • Bahceci E; Astellas Pharma Global Development, Northbrook, IL; and.
  • Hill J; Astellas Pharma Global Development, Northbrook, IL; and.
  • Liu C; Astellas Pharma Global Development, Northbrook, IL; and.
  • Xie Z; Invivoscribe, Inc, San Diego, CA.
  • Carson AR; Invivoscribe, Inc, San Diego, CA.
  • McClain V; Invivoscribe, Inc, San Diego, CA.
  • Stenzel TT; Invivoscribe, Inc, San Diego, CA.
  • Miller JE; Invivoscribe, Inc, San Diego, CA.
Blood Adv ; 2(8): 825-831, 2018 04 24.
Article em En | MEDLINE | ID: mdl-29643105

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Neoplasia Residual / Sequenciamento de Nucleotídeos em Larga Escala Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Neoplasia Residual / Sequenciamento de Nucleotídeos em Larga Escala Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article